Table 1.
Characteristic mean (SD) or N (%)a | Overall NC-CanCORS |
EMT study sample |
P value | ||
---|---|---|---|---|---|
(N = 990) | (N = 190) | ||||
Age at baseline (years) | 66.3 | 13.2 | 66.6 | 13.1 | 0.8 |
Sex | 0.6 | ||||
Male | 488 | 49.3 % | 90 | 47.4 % | |
Female | 502 | 50.7 % | 100 | 52.6 % | |
Race | 0.6 | ||||
Non-hispanic white | 762 | 77.0 % | 150 | 78.9 % | |
Other | 228 | 23.0 % | 40 | 21.1 % | |
Tumor stage | 0.9 | ||||
Local | 437 | 51.1 % | 100 | 52.6 % | |
Regional | 311 | 36.4 % | 66 | 34.7 % | |
Distant | 107 | 12.5 % | 24 | 12.6 % | |
Missing/noninformative | 135 | 0 | |||
Tumor location | 0.07 | ||||
Proximal | 279 | 42.9 % | 82 | 50.9 % | |
Distal | 371 | 57.1 % | 79 | 49.1 % | |
Missing/noninformative | 340 | 29 | |||
Tumor grade | 0.4 | ||||
Well/moderately differentiated | 539 | 83.7 % | 129 | 81.1 % | |
Poorly/not differentiated | 105 | 16.3 % | 30 | 18.9 % | |
Missing/noninformative | 346 | 31 | |||
Neoadjuvant chemotherapy | 0.3 | ||||
Yes | 46 | 8.5 % | 8 | 5.7 % | |
No | 496 | 91.5 % | 132 | 94.3 % | |
Missing/noninformative | 448 | 50 | |||
Neoadjuvant radiation | 0.09 | ||||
Yes | 41 | 7.6 % | 5 | 3.6 % | |
No | 501 | 92.4 % | 135 | 96.4 % | |
Missing/noninformative | 448 | 50 | |||
Died within 5 years of baseline | 366 | 37.0 % | 62 | 32.6 % | 0.3 |
Percentages are for informative non-missing data